Peer Support Models for People With a History of Injecting Drug Use Undertaking Assessment and Treatment for Hepatitis C Virus Infection
Peer Support Models for People With a History of Injecting Drug Use Undertaking Assessment and Treatment for Hepatitis C Virus Infection
复制标题
DOI：
10.1093/cid/cit297
复制
发表时间：
2013-08-15
影响因子：
11.8
通讯作者：
Bath, Nicky
中科院分区：
文献类型：
--
作者：
Crawford, Sione;Bath, Nicky
注射吸毒者（PWID）是受丙型肝炎病毒影响最大的群体；然而，治疗的接受程度很低。PWID与卫生保健工作者之间的接触的特点是不信任和歧视。同伴支持丙型肝炎病毒是克服这些障碍的一种方法。慢性疾病管理的同伴支持模式已成功地应用于其他疾病。HCV同伴支持模式已在各种环境中实施，但包括阿片类药物替代治疗的模式更为常见。大多数模型不是由服务生成（由提供者主导）就是由社区控制（由对等主导）。同伴支持模式已经成功实施，取得了一系列成果，包括增加了治疗知识和吸收，改善了服务提供。对等节点和服务之间的真正伙伴关系在各个模型中都很常见，并为客户和服务带来了积极的转变。建议进一步调查同伴对丙肝病毒治疗的支持及其对个人和服务的影响。
People who inject drugs (PWID) are the group most affected by HCV; however, treatment uptake has been low. Engagement between PWID and healthcare workers has been characterized by mistrust and discrimination. Peer support for HCV is one way to overcome these barriers. Peer support models for chronic disease management have been successfully applied for other diseases. HCV peer support models have been implemented in various settings, but those that include opioid substitution treatment have been more common. Most models have been either service generated (provider led) or community controlled (peer led). Peer support models have been implemented successfully, with a range of outcomes including increased treatment knowledge and uptake and improved service provision. Genuine partnerships between peers and services were common across models and led to positive transformations for both clients and services. Further investigation of peer support for HCV treatment and its impact on both individuals and services is recommended.